Literature DB >> 8894485

Proinsulin levels predict the development of non-insulin-dependent diabetes mellitus (NIDDM) in Japanese-American men.

S E Kahn1, D L Leonetti, R L Prigeon, E J Boyko, R W Bergstom, W Y Fujimoto.   

Abstract

Disproportionate hyperproinsulinaemia is a manifestation of the beta-cell dysfunction observed in NIDDM. However, it is unclear when this abnormality develops and whether it predicts the development of the disease. To examine whether changes in proinsulin levels predict the development of NIDDM, baseline measurements of proinsulin and immunoreactive insulin levels were made in 87 second-generation Japanese-American men, a population at high risk for the subsequent development of NIDDM. Subjects were categorized at baseline using WHO criteria as having normal glucose tolerance (NGT; n = 49) or impaired glucose tolerance (IGT; n = 38). After a 5-year follow-up period, subjects were recategorized as having NGT, IGT or NIDDM using the same criteria. During follow-up, 16 subjects developed NIDDM while 71 were NGT or IGT. At baseline, individuals who subsequently developed NIDDM were more obese as measured by intra-abdominal fat area on computed tomography (p = 0.046), had higher fasting glucose (p = 0.0042), 2-h glucose (p = 0.0002), fasting C-peptide (p = 0.0011), fasting proinsulin levels (p = 0.0033), and had disproportionate hyperproinsulinaemia (p = 0.056) when compared to those who remained NGT or IGT after 5 years of follow-up. These findings suggest that alterations in proinsulin levels may also predict the subsequent development of NIDDM.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8894485

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  7 in total

1.  Pancreatic dysfunction in severe obesity.

Authors:  A J Drake; L Greenhalgh; R Newbury-Ecob; E C Crowne; J P Shield
Journal:  Arch Dis Child       Date:  2001-03       Impact factor: 3.791

2.  Characterisation of morbidity in a UK, hospital based, obesity clinic.

Authors:  M A Sabin; A L Ford; J M P Holly; L P Hunt; E C Crowne; J P H Shield
Journal:  Arch Dis Child       Date:  2005-10-24       Impact factor: 3.791

3.  Alterations in proinsulin and insulin dynamics, HDL Cholesterol and ALT after gastric bypass surgery. A 42-months follow-up study.

Authors:  Hans-Erik Johansson; Arvo Haenni; Margareta Ohrvall; Magnus Sundbom; Björn Zethelius
Journal:  Obes Surg       Date:  2009-02-20       Impact factor: 4.129

4.  Carboxypeptidase E mediates palmitate-induced beta-cell ER stress and apoptosis.

Authors:  Kristin D Jeffrey; Emilyn U Alejandro; Dan S Luciani; Tatyana B Kalynyak; Xiaoke Hu; Hong Li; Yalin Lin; R Reid Townsend; Kenneth S Polonsky; James D Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-11       Impact factor: 11.205

5.  Both fasting and glucose-stimulated proinsulin levels predict hyperglycemia and incident type 2 diabetes: a population-based study of 9,396 Finnish men.

Authors:  Jagadish Vangipurapu; Alena Stančáková; Teemu Kuulasmaa; Johanna Kuusisto; Markku Laakso
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

6.  Gastric bypass alters the dynamics and metabolic effects of insulin and proinsulin secretion.

Authors:  H-E Johansson; M Ohrvall; A Haenni; M Sundbom; B Edén Engström; F A Karlsson; B Zethelius
Journal:  Diabet Med       Date:  2007-09-26       Impact factor: 4.359

7.  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Authors:  Bernd Richter; Bianca Hemmingsen; Maria-Inti Metzendorf; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.